GlassScriptPhysician profile
Fredrick Ogugua
NPI 1609339902
$6,144.77
in general payments reported to CMS, 2019-2025
26 companies · $2,382 in 2025
The $2,382 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.28 · 2023: $1,301 · 2024: $2,440 · 2025: $2,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,510 · Education: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,510.07 |
| Education | $613.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $645.98 | 2023-2025 | General - Vascular Access, Watchman Access System, Accolade Sr |
| Novartis Pharmaceuticals Corporation | $643.46 | 2024-2025 | |
| Abiomed | $640.11 | 2024-2025 | Impella |
| Medtronic, INC. | $539.93 | 2022-2025 | Resolute Onyx, Symplicity G3, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $476.67 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint, Cardiomems |
| Edwards Lifesciences Corporation | $450.51 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $328.78 | 2024-2025 | |
| Inari Medical, INC. | $275.18 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $242.73 | 2023 | |
| Chiesi USA, INC. | $238.18 | 2023-2024 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.52 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $184.46 | 2023-2025 | Camzyos |
| Amgen INC. | $174.21 | 2023-2024 | Repatha |
| Shockwave Medical, INC | $157.10 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Teleflex LLC | $147.39 | 2025 | Turnpike, Vascband, Supercross |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.46 | 2024 | Lifevest |
| Esperion Therapeutics, INC. | $101.41 | 2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $96.61 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $65.55 | 2023-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $60.95 | 2023-2024 | Farxiga |
| Becton, Dickinson and Company | $52.40 | 2025 | Hemosphere |
| Cardiva Medical, INC. | $48.99 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Terumo Medical Corporation | $46.24 | 2023 | Optitorque, Glidewire, Heartrail |
| Bayer Healthcare Pharmaceuticals INC. | $33.35 | 2025 | |
| Lantheus Medical Imaging, INC. | $26.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredrick Ogugua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.